Biovica, active in cancer biomarkers, announced that clinical data - demonstrating that DiviTum can be used as a dynamic, non-invasive biomarker for metastatic breast cancer patients treated with endocrine therapy and palbociclib - will be presented at the San Antonio Breast Cancer Symposium, December 10-14, 2019, the world’s largest scientific congress focusing on breast cancer.
November 20, 2019
· 2 min read